Article Versions Notes

Zazuli Z, Otten LS, Drögemöller BI, Medeiros M, Monzon JG, Wright GEB, Kollmannsberger CK, Bedard PL, Chen Z, Gelmon KA, et al. Outcome Definition Influences the Relationship between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients. Genes. 2019; 10(5):364. https://doi.org/10.3390/genes10050364

Zazuli, Zulfan, Leila S. Otten, Britt I. Drögemöller, Mara Medeiros, Jose G. Monzon, Galen E. B. Wright, Christian K. Kollmannsberger, Philippe L. Bedard, Zhuo Chen, Karen A. Gelmon, and et al. 2019. "Outcome Definition Influences the Relationship between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients" Genes 10, no. 5: 364. https://doi.org/10.3390/genes10050364

Zazuli, Z., Otten, L. S., Drögemöller, B. I., Medeiros, M., Monzon, J. G., Wright, G. E. B., Kollmannsberger, C. K., Bedard, P. L., Chen, Z., Gelmon, K. A., McGoldrick, N., Kitchlu, A., Vijverberg, S. J. H., Masereeuw, R., Ross, C. J. D., Liu, G., Carleton, B. C., & Maitland-van der Zee, A. H. (2019). Outcome Definition Influences the Relationship between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients. Genes, 10(5), 364. https://doi.org/10.3390/genes10050364